First oral drug for spinal cord injury improves movement in mice
An experimental oral drug given to mice after a spinal cord injury was effective at improving limb movement after the injury, a new study shows.
Neuroscience
Jan 08, 2013 |
5 / 5 (7) |
0
|
Common food preservative may slow, even stop tumor growth
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Cancer
Oct 31, 2012 |
4.8 / 5 (6) |
0
|
'Micro'-chemo and cancer pill combo tested in liver cancer patients
A combination of an oral drug, called sorafenib, and a method for injecting microbeads of chemotherapy directly into tumors has been proven safe for liver cancer patients and may improve outcomes for those who have these ...
Cancer
Sep 30, 2011 |
5 / 5 (3) |
0
|
Double duty: Anti-HIV topical gel also protects against herpes virus
HIV infection is commonly associated with other sexual infections, such as herpes simplex virus (HSV). Infection with HSV facilitates the risk of HIV infection and negatively impacts the clinical course of HIV disease. Therefore, ...
HIV & AIDS
Oct 19, 2011 |
3.7 / 5 (3) |
0
New oral drug found to reduce relapses in multiple sclerosis patients
A new oral drug has been shown in a large international clinical trial to significantly reduce the relapse rate of people with multiple sclerosis and to slow the progression of the disease.
Medications
Oct 06, 2011 |
5 / 5 (1) |
0
|
Study finds interventions to prevent Type 2 diabetes give good return on investment
Programs to prevent or delay type 2 diabetes in high-risk adults would result in fewer people developing diabetes and lower health care costs over time, researchers conclude in a new study funded by the National Institutes ...
Diabetes
Mar 22, 2012 |
5 / 5 (1) |
0
Early clinical data show galeterone safe, effective against prostate cancer
Patients with castration-resistant prostate cancer had limited side effects and in many cases a drop in prostate-specific antigen expression with galeterone (TOK-001), a small-molecule oral drug, according to phase I data ...
Cancer
Apr 01, 2012 |
5 / 5 (1) |
0
Certain birth control pills may carry higher blood clot risk: FDA
(HealthDay) -- U.S. health officials announced Tuesday that birth controls pills containing drospirenone -- a man-made version of the hormone progesterone -- may be associated with a higher risk of blood clots ...
Medications
Apr 10, 2012 |
5 / 5 (1) |
0
|
Study shows benefit of new maintenance therapy for multiple myeloma
Multiple myeloma is a form of cancer where the plasma cells in the bone marrow grow out of control, causing damage to bones as well as predisposing patients to anemia, infection and kidney failure. A medical procedure called ...
Cancer
May 11, 2012 |
5 / 5 (1) |
0
|
Gonorrhea resistant to all but one antibiotic: CDC
(HealthDay) -- With options shrinking to a single antibiotic that can fight resistant strains of gonorrhea, U.S. health authorities issued revised guidelines for treating the sexually transmitted bacteria ...
Diseases, Conditions, Syndromes
Aug 09, 2012 |
5 / 5 (1) |
1
|
Children taking steroids for asthma are slightly shorter than peers
Children who use inhaled steroid drugs for asthma end up slightly shorter at their full adult height than children who don't use the drugs, new results from a comprehensive asthma study show.
Immunology
Sep 03, 2012 |
5 / 5 (1) |
1
|
New evidence on easing inflammation of brain cells for Alzheimer's disease
New research proves the validity of one of the most promising approaches for combating Alzheimer's disease (AD) with medicines that treat not just some of the symptoms, but actually stop or prevent the disease ...
Alzheimer's disease & dementia
Oct 03, 2012 |
5 / 5 (1) |
0
New drug overcomes resistance in patients with rare sarcoma
A new targeted drug demonstrated its ability to control metastatic gastrointestinal stromal tumor, an uncommon and life-threatening form of sarcoma, after the disease had become resistant to all existing therapies, report ...
Cancer
Nov 21, 2012 |
5 / 5 (1) |
0
|
US approves first pill to help prevent HIV
(AP) — The Food and Drug Administration on Monday approved the first drug shown to reduce the risk of HIV infection, the latest milestone in the 30-year battle against the virus that causes AIDS.
HIV & AIDS
Jul 16, 2012 |
4 / 5 (1) |
0
ONO-4641 pill reduced number of MS lesions in Phase II trial
An investigational oral drug called ONO-4641 reduced the number of lesions in people with multiple sclerosis (MS), according to the results of a phase two clinical trial to be presented as Emerging Science (formerly known ...
Neuroscience
Apr 16, 2012 |
3 / 5 (1) |
0
